AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

APREMILAST

15 registrations across 3 African markets— 11 active

Markets with APREMILAST

Recent registrations

Brand / ProductMarketHolderStatusExpires
APREMILAST 20 mg GLENMARK🇿🇦South AfricaGlenmark Pharmaceuticals South Africa (Pty) LtdactiveFeb 2028
APREMILAST 30 mg GLENMARK🇿🇦South AfricaGlenmark Pharmaceuticals South Africa (Pty) LtdactiveFeb 2028
APTIKA 10 mg🇿🇦South AfricaGlenmark Pharmaceuticals South Africa (Pty) LtdactiveFeb 2028
APTIKA 20 mg🇿🇦South AfricaGlenmark Pharmaceuticals South Africa (Pty) LtdactiveFeb 2028
APTIKA 30 mg🇿🇦South AfricaGlenmark Pharmaceuticals South Africa (Pty) LtdactiveFeb 2028
APREMILAST 10 mg GLENMARK🇿🇦South AfricaGlenmark Pharmaceuticals South Africa (Pty) LtdactiveFeb 2028
APREZO STARTER PACK
Film-Coated Tablet
🇰🇪KenyaGlenmark Pharmaceuticals LimitedactiveSept 2026
OTEZLA 10 mg🇿🇦South AfricaAmgen South Africa (Pty)LtdsuspendedJul 2025
OTEZLA Starter Pack🇿🇦South AfricaAmgen South Africa (Pty)LtdsuspendedJul 2025
OTEZLA 20 mg🇿🇦South AfricaAmgen South Africa (Pty)LtdsuspendedJul 2025
OTEZLA 30 mg🇿🇦South AfricaAmgen South Africa (Pty)LtdsuspendedJul 2025
APREMILAST
Oral Solid Ordinary Film- Coated Tablets
🇺🇬UgandaGLENMARK PHARMACEUTICA LS LTDactive
APREMILAST
Oral Solid Ordinary Film-Coated Tablets
🇺🇬UgandaGLENMARK PHARMACEUTICA LS LTDactive
APREMILAST
Oral Solid Ordinary Film- Coated Tablets
🇺🇬UgandaGLENMARK PHARMACEUTICA LS LTDactive
APREMILAST
Oral Solid Ordinary Film-Coated Tablets
🇺🇬UgandaGLENMARK PHARMACEUTICA LS LTDactive

APREMILAST in Africa — Regulatory Overview

APREMILAST is registered across 3 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Uganda, Kenya. AfricaRegulatory refreshes this data daily from official government sources.

Of the 15 registrations, 11 (73%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.